Share Price:

APNASPENAspen Pharmacare Hldgs12115-25 (-0.21%)
Our Response to Covid
Country Sites

Aspen will be in a closed period from 1 January 2025 until the publication of the Interim Results on the JSE SENS platform on 3 March 2025.

Author: Shauneen Beukes

Aspen donates life-saving emergency relief to patients in Turkey and Syria

Johannesburg – Aspen, a leading global specialty and branded multinational pharmaceutical company, has positively responded to humanitarian calls for relief following the devastating 7.8 magnitude earthquake, along with a series of strong tremors and aftershocks, that tore through southeast Turkey and northwest Syria on 6 February 2023.   Stavros Nicolaou, Aspen Group Senior Executive Strategic… Continue reading Aspen donates life-saving emergency relief to patients in Turkey and Syria

Tragic passing of Riaan Verster (46)

Durban, South Africa – JSE Limited listed Aspen Pharmacare Holdings Limited (APN), regrets to announce the untimely and tragic passing of Riaan Verster, Aspen Group Executive: Governance & Communications, on Saturday 28 January 2023. Riaan regrettably succumbed to his injuries sustained in a motor cycle accident.   Stephen Saad, Aspen Group Chief Executive, said, “Riaan was a dear… Continue reading Tragic passing of Riaan Verster (46)

Aspen, CEPI and the Bill & Melinda Gates Foundation expand commitments to improve access to vaccines in Africa

Stephen Saad, Aspen Group Chief Executive

New funding supports technology transfer from Serum Institute to Aspen to manufacture routine vaccines in Africa, for Africa Collaboration supports sustainable manufacturing capacity for African-produced vaccines for future epidemics and pandemics   Durban, South Africa – JSE Limited listed Aspen Pharmacare Holdings Limited (“Aspen”) a global multinational specialty pharmaceutical company,  announced that it will receive USD30 million… Continue reading Aspen, CEPI and the Bill & Melinda Gates Foundation expand commitments to improve access to vaccines in Africa

Aspen closes EUR 1,26 billion syndicated loan facilities

Durban, South Africa – JSE Limited listed Aspen Pharmacare Holdings Limited (APN), a global multinational specialty pharmaceutical company, has closed a multi-currency, syndicated term loan and revolving credit facilities agreement. These facilities, totalling circa EUR 1,26 billion equivalent, were put in place to refinance Aspen’s 2018 syndicated loan facilities.    The facilities were structured across EUR, ZAR and… Continue reading Aspen closes EUR 1,26 billion syndicated loan facilities

Aspen delivers double digit organic growth in normalised EBITDA, operating profit and earnings

Johannesburg – JSE-listed Aspen Pharmacare Holdings Limited (APN), a global multinational specialty pharmaceutical company, is pleased to report reviewed provisional Group financial results for the year ended 30 June 2022.   SALIENT FEATURES Revenue from continuing operations increased by 2% (+5% in constant exchange rate (“CER”)) to R38,6 billion (FY2021: R37,8 billion); Normalised EBITDA from… Continue reading Aspen delivers double digit organic growth in normalised EBITDA, operating profit and earnings

Aspen hosts more than 800 Mandela Day activities over 12 years

“Our purpose, To improve the health and quality of life of patients is closely aligned to the ethos of Mandela Day. This has been clearly demonstrated through our endeavours to provide citizens across the continent with vaccines which are manufactured in South Africa for Africa.”   Durban – JSE Limited listed Aspen Pharmacare Holdings Limited… Continue reading Aspen hosts more than 800 Mandela Day activities over 12 years

Aspen donates life-saving medicines for 62000 surgeries in Ukraine

Aspen has donated life saving medicines valued at R11 million to facilitate 62 000 surgeries in Ukraine

Johannesburg, South Africa – Aspen Pharmacare, Africa’s largest pharmaceutical company, has extended its support to Ukraine with donations of life-saving medicines required for urgent surgical intervention. This action further demonstrates Aspen’s ongoing commitment to saving lives and improving the quality of life of patients irrespective of their location or circumstances. Stavros Nicolaou Aspen Senior Executive… Continue reading Aspen donates life-saving medicines for 62000 surgeries in Ukraine

Aspen delivers double digit organic revenue grown in constant exchange rates

Stephen Saad, Aspen Group Chief Executive

  Johannesburg – JSE Limited listed Aspen Pharmacare Holdings Limited (APN), a global multinational specialty pharmaceutical company, has announced unaudited interim financial results for the six months ended 31 December 2021. SALIENT RESULTS Aspen reported the following salient results: Revenue from continuing operations increased by 4% (+10% in constant exchange rate (“CER”) to R19,4 billion… Continue reading Aspen delivers double digit organic revenue grown in constant exchange rates

Our Purpose

Find out more
To improve the health and quality of life of patients.

Our Vision

Find out more
To deliver value to all our stakeholders as a responsible corporate citizen that provides high-quality, affordable medicines globally.

Our Values

Find out more
Define the foundation on which Aspen has been built. These are the values we share as we work together toward achieving the vision of the Group.
aspen-holdings-logo-white-img

Aspen Holdings
www.aspenpharma.com
Hotline (South Africa)
0800 122 912

Medical Careline (South Africa) 0800 118 088

Facebook-f Twitter-square Instagram Linkedin

About Aspen

We Care

Careers

Contact Us

ASPEN PHARMACARE HOLDINGS LTD:
Switchboard: +27 31 580-8600

Aspen Place
9 Rydall Vale Park
Douglas Saunders Drive
La Lucia Ridge
South Africa

Closed Period

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform scheduled to be released on 1 March 2023.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.